Stability of Transmembrane Amyloid ß-Peptide and Membrane Integrity Tested by Molecular Modeling of Site-Specific Aß$_{42}$ Mutations by Poojari, Chetan & Strodel, Birgit
Stability of Transmembrane Amyloid b-Peptide and
Membrane Integrity Tested by Molecular Modeling of
Site-Specific Ab42 Mutations
Chetan Poojari1, Birgit Strodel1,2*
1 Institute of Complex Systems: Structural Biochemistry, Forschungszentrum Ju¨lich GmbH, Ju¨lich, Germany, 2 Institute of Theoretical and Computational Chemistry,
Heinrich Heine University Du¨sseldorf, Du¨sseldorf, Germany
Abstract
Interactions of the amyloid b-protein (Ab) with neuronal cell membranes, leading to the disruption of membrane integrity,
are considered to play a key role in the development of Alzheimer’s disease. Natural mutations in Ab42, such as the Arctic
mutation (E22G) have been shown to increase Ab42 aggregation and neurotoxicity, leading to the early-onset of Alzheimer’s
disease. A correlation between the propensity of Ab42 to form protofibrils and its effect on neuronal dysfunction and
degeneration has been established. Using rational mutagenesis of the Ab42 peptide it was further revealed that the
aggregation of different Ab42 mutants in lipid membranes results in a variety of polymorphic aggregates in a mutation
dependent manner. The mutant peptides also have a variable ability to disrupt bilayer integrity. To further test the
connection between Ab42 mutation and peptide–membrane interactions, we perform molecular dynamics simulations of
membrane-inserted Ab42 variants (wild-type and E22G, D23G, E22G/D23G, K16M/K28M and K16M/E22G/D23G/K28M
mutants) as b-sheet monomers and tetramers. The effects of charged residues on transmembrane Ab42 stability and
membrane integrity are analyzed at atomistic level. We observe an increased stability for the E22G Ab42 peptide and a
decreased stability for D23G compared to wild-type Ab42, while D23G has the largest membrane-disruptive effect. These
results support the experimental observation that the altered toxicity arising from mutations in Ab is not only a result of the
altered aggregation propensity, but also originates from modified Ab interactions with neuronal membranes.
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Introduction
Alzheimer’s disease (AD) is the most common form of late-onset
dementia resulting in the progressive impairment of memory and
executive function [1]. It is associated with synaptic loss,
abnormalities in neuronal function, an increase in neuronal cell
death, and the extracellular accumulation of senile plaques
composed of the amyloid b-peptide (Ab) [2,3]. In general, Ab is
a normal product of cellular metabolism throughout life and
circulates as a soluble peptide in biological fluids. It is produced
through posttranslational processing of the amyloid precursor
protein (APP), a type-1 membrane integral glycoprotein via
sequential cleavage by b- and c-secretases [4]. Of the proteolytic
cleavage products, which typically contain 39 to 43 residues, Ab42
is recognized as the most important alloform based on its ability to
elicit neurotoxicity. It is the most prevalent alloform found in
amyloid plaques, and has the highest propensity to aggregate into
fibrils and plaques [5,6]. The ‘amyloid cascade hypothesis’
proposes that assemblies of Ab initiate a process leading to
neuronal dysfunction and cell death [7]. The most potent
neurotoxic assemblies appear to be oligomeric, rather than
fibrillar, in nature [8,9]. There is acceptable evidence suggesting
that Ab exerts its cytotoxic effect by interacting with membranes of
neurons and other cerebral cells, such as astrocytes, microglial and
cerebral endothelial cells [10,11]. A potential pathway for Ab
toxicity lies in its ability to alter biophysical membrane properties
[12–14], causing membrane disruption and permeability [15–17]
and thereby allowing the leakage of ions, particularly calcium ions
[17–20].
Familial forms of AD increase Ab production or the propensity
of Ab to aggregate [7]. Until now four genes affecting APP,
presenilin-1 (PS-1), presenilin-2 (PS-2) and apolipoprotein E have
been identified to be linked to AD. So far 19 pathogenic missense
mutations have been discovered in APP, of which seven are
located in the region encoding Ab. English (H6R) [21] and Tottori
(D7N) [22] mutants show increased fibril elongation than wild-
type (WT) Ab [23]. The Dutch mutant (E22Q) [24,25] favors Ab
production and leads to a b-sheet structure [26–29]. The Flemish
mutant (A21G) [30] forms stable oligomers with decreased fibril
formation [31], while the Arctic mutation (E22G) [32] increases
neurotoxic protofibril production [33,34]. The Italian mutant
(E22K) promotes faster aggregation of Ab40 and Ab42 [29] and the
Iowa mutant (D23N) [35] forms fibrils faster than WT Ab.
In a recent study, intact lipid bilayers were exposed to
predominantly monomeric preparations of WT or different
mutant forms of Ab40, and atomic force microscopy (AFM) was
used to monitor aggregate formation and morphology as well as
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bilayer integrity over a 12 hour period [36]. The goal of this study
was to determine how point mutations in Ab, which alter peptide
charge and hydrophobic character, influence interactions between
Ab and the lipid surface. The Arctic, Italian, Iowa and Flemish
mutations were considered. While fibril morphology did not
appear to be significantly altered when mutants were prepared
similarly and incubated under free solution conditions, aggrega-
tion in the lipid membranes resulted in a variety of polymorphic
aggregates in a mutation dependent manner. It was further found
that the ability of Ab to disrupt the structural integrity of bilayers is
notably modulated by these mutations. An enhanced bilayer
disruption was reported for the Arctic mutation. It was speculated
that, in comparison to WT Ab, the increased hydrophobic nature
of E22G Ab increases its bilayer insertion. The membrane-bound
oligomers of the Iowa mutation were extremely stable and the
bilayer developed small, discrete areas of disrupted lipid
morphology. Based on overall electrostatic and hydrophobic
properties of D23N Ab this finding could not be explained [36].
One of the aims of the current molecular simulation study is to
provide a better understanding of the experimental findings
provided in [36]. In general, theoretical approaches are a
complement to experimental studies probing the connection
between Ab42 mutations, aggregation [37,38] and Ab–membrane
interactions [39,40]. So far various computational studies of Ab
interacting with lipids have been performed to gain structural
information at an atomistic level [41–62]. Structural models and
experimental evidence support to the claim that transmembrane
Ab is an assembly of loosely associated mobile b-sheet subunits
[41–43,48]. In a recent study, Nussinov and co-workers used
molecular simulations to demonstrate that amino acid substitu-
tions help to infer which residues are essential for Ab channel
structures [46]. The current study builds on our previous work,
where we reported on the effects of lipid type and peptide
oligomerization on membrane-bound WT Ab42 using molecular
dynamics (MD) simulations on the sub-microsecond timescale
[49]. We considered helical and b-sheet conformations embedded
in zwitterionic palmitoyl-oleoyl phosphatidylcholine (POPC) and
dipalmitoyl phosphatidylcholine (DPPC), and anionic palmitoyl-
oleoyl phosphatidylglycerol (POPG) lipid bilayers. We observed
that POPC increases the stability of transmembrane Ab42.
Hydrophobic mismatch and lipid order of DPPC, and anionic
surface charges of POPG bilayers are responsible for structural
instabilities of Ab42 in these bilayers. From the considered
structures the b-sheet tetramer was found to be most stable as a
result of interpeptide interactions [48]. We performed a quanti-
tative analysis of the translocation of water in the Ab42 -bilayer
systems. We observed that this process is generally fast (within a
few nanoseconds) yet generally slower than in the absence of Ab42
in the bilayers. The rate limiting step is the permeation across the
hydrophobic core, where interactions between Ab42 and perme-
ating H2O molecules slow the translocation process. Finally, we
showed that the b-sheet tetramer allows more water molecules to
pass through the bilayer compared to monomeric Ab42 [49].
The goal of the present study is to investigate the effects of the
charged residues K16, E22, D23 and K28 on the stability of
transmembrane Ab42 in a POPC bilayer and their role on
membrane integrity. To this end, we perform mutational studies
for monomeric and tetrameric b-sheet structures of Ab42. We
choose Ab42 to be in the b state because there is mounting
evidence that amyloid oligomers adopt a b conformation in the
membrane [16,63–66]. Circular dichroism (CD) spectroscopy
indicated that Ab42 when incorporated in a lipid bilayer adopts
more b-sheet structure in comparison to the associated
peptide, which is largely unstructured [16]. Furthermore, it was
demonstrated that Ab42 incorporation into lipid bilayers causes
membrane destabilization by increasing membrane fluidity [16].
Studies on Ab40 fused into a POPC bilayer argue for damage of
bilayer integrity caused by small Ab assemblies with a large
proportion of b-sheet structure, which are embedded in the lipid
bilayer [63]. Using attenuated total reflection Fourier transform
infrared (ATR-FTIR) spectroscopy, de Planque et al. were able to
conclude that the channel-like bahavior of Ab is not caused by
helical bundles of transmembrane Ab peptides [63]. Another study
employing thioflavin T fluorescence and CD spectroscopy to
characterize Ab membrane binding and permeabilization revealed
that membrane leakage is directly correlated to Ab oligomeriza-
tion and b-sheet formation [64]. In contrast, membrane-bound a-
helical Ab40, which is only observed at high lipid-to-peptide ratios,
has a low tendency to aggregate and causes only minor membrane
leakage [64]. Other recent studies show that it seems to be a
generic feature of amyloid proteins to permeabilize membranes
when assembled into a b-sheet oligomer, thereby inflicting
cytotoxicity [15,66–68].
However, the structure of Ab in membranes is still not known.
Therefore, models based on previous experimental and simulation
results have to be designed for simulation studies investigating
membrane-bound Ab. To this end, we employ a bottom-up
approach using structures predicted to be favourable for the
membrane-inserted monomer and small oligomers as possible
subunits for larger trans-membrane Ab aggregates [48,49]. In the
current study, we consider the Arctic mutant E22G Ab42, the
‘Arctic-type’ D23G mutant [69] in order to have a direct
comparison with E22G, and the double mutant E22G/D23G.
For the investigation of the effects of the positive charges of K16
and K28 we mutate these residues to methionine leading to the
double mutant K16M/K28M Ab42. We choose methionine since,
compared to all other amino acids, it has the smallest free energy
barrier for translocation across the membrane headgroup region
in either direction [70,71]. Finally, we study the quadruple mutant
K16M/E22G/D23G/K28M where all peptide charges in the
transmembrane region are removed. Our simulation results for
WT, E22G and D23G Ab42 allow a better explanation of the
experimental findings testing the connection between Ab point
mutations and Ab -induced membrane disruption [36]. To our
knowledge, this study is the first computational one to investigate
the effects of the familial E22G mutation on Ab –membrane
interactions.
Results and Discussion
In a recent study we investigated membrane-bound WT Ab42 as
a b-sheet monomer and tetramer and as a helix [49]. The results
obtained for the b-sheet structures will serve as comparison for the
Ab42 mutants considered in the current study. The monomeric
and tetrameric transmembrane Ab42 structures, from which our
MD simulations were initiated, are shown in Fig. 1 [48].
Ab42 Monomer: Effects of Charge Removal on
Transmembrane Stability
WT and Ab42 mutants were studied as monomer in the
transmembrane b-sheet conformation in 500 ns MD simulations.
The Ab42 monomer structures collected at the end of the MD
simulations are shown in Fig. 2.
Transmembrane Ab42 forms stable b-sheets. Like WT
Ab42 [49], all of the mutants remain in the lipid bilayer during the
MD simulations. In general, the root mean square deviations
(RMSD) and root mean square fluctuations (RMSF) for the
peptide backbone atoms, which are presented in Fig. 3A and B,
Transmembrane Ab Mutants
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reveal a similar stability and fluctuation pattern for the Ab42
variants. D23G has the largest RMSD with values between 0.6
and 0.7 nm from the starting structure, while the RMSD of the
other Ab42 variants fluctuates around 0.4 nm. The RMSD and
RMSF are not sufficient to assess the structural change and
stability of transmembrane peptides. For example, both E22G and
K16M/K28M have average RMSD values of 0.40 nm, while the
conformations shown in Fig. 2 reveal that the structures are
different inside the membrane. Therefore, we consider further
observables in order to evaluate the stability of the membrane-
inserted Ab42 mutants. To quantify the peptide motion along the
membrane normal (i.e., the z-direction) inside the bilayer, we
compute the center of mass motion of residues 25–30 in the lower
Ab42 loop. The results of this analysis in Fig. 3C indicate that, after
the initial 100 ns, the position of Ab42 inside the membrane is
stable. Only for E22G and D23G a more pronounced motion
along z is observed leading to average positions of 2.960.2 nm and
3.360.2 nm, respectively. For the other four Ab42 variants the
average position inside the membrane is 2.5–2.6 nm with a
standard deviation of 0.1 nm. The origin of the motion of E22G
and D23G will be discussed below. Despite the removal of charged
residues at the lipid–water interfaces, which in principle might act
as electrostatic anchors in the transmembrane b-sheet structure of
WT Ab42, the transmembrane b-sheet has a high propensity to
stay inside the membrane. This is attributable to the many
hydrophobic amino acids between residues V24–A42, irrespective
of the backbone carbonyl and amide groups which are not H-
bonded in the b-sheet structure [49]. Between 14 and 17 out of the
26 residues between L17 and A42 are in b-conformation (Table 1
and Fig. 3D) with only minor differences in the average b-strand
content and its fluctuation between the different Ab42 variants.
These transmembrane b-sheets are thus stable what is further
supported by the final MD states and secondary structure analysis
(Figs. S1–S3 in File S1).
It should be noted, though, that is important to consider that the
force field chosen may affect the outcome of the study. The
systematic evaluation of recent force fields has shown that many of
them overly bias helical structures [72,73], while the GROMOS96
53A6 parameter set [74] employed here may overstabilize
extended configurations and understabilize helices [75]. However,
we recently demonstrated that the GROMOS96 53A6 force field
is able to reproduce the NMR shifts for Ab40 and Ab42, indicating
that the Ab structures it produces are in agreement with
experimental observations [76]. Furthermore, the GROMOS96
53A6 protein force field is compatible with a modified version of
the popular Berger force field for lipids [77]. In our previous work
[49] and also in work by Lemkul and Bevan [50–53] this
combination of protein and lipid force fields was used to study
Ab42 –membrane interactions. These studies revealed that Ab in
membranes is stable as both helix and b-sheet. The b-strand
content is enhanced by the presence of raft membranes containing
ganglioside GM1 [52] and the aggregation of Ab inside the
membrane [49,53].
Ab42 mutants display different transmembrane struc-
tures. The Ab42 mutants exhibit somewhat higher mean
RMSD values than WT Ab42. While the RMSD analysis is a
measure for the overall motion of the peptide residues, the RMSF
highlights the flexibility of individual Ab42 residues. The RMSF
results in Fig. 3B indicate that the transmembrane Ab42 peptide
(WT and mutants) is most flexible in the three turn regions, where
the first one (residues 5–11) is outside the lipid bilayer and the
other two (residues D23–G29 and G37–G38, respectively) are
located within the hydrophobic core. The degree of fluctuation is
different for each Ab42 variant and will be discussed below for
each mutant. WT and E22G/D23G Ab42 are most flexible
between residues 22 and 30. This WT result is at first sight
surprising, as it is the only monomeric b-sheet where this turn
region is occasionally stabilized by the intramolecular D23G–K28
salt bridge (Fig. S6 in File S1). However, the breakage and
formation of the salt bridge induces structural flexibility. More-
over, while the existence of the D23G–K28 salt bridge constrains
the turn it does not prevent the loss of b structure in this region,
which converts to coil-turn-coil after 400 ns of this simulation (Fig.
S1 in File S1). The instability of the WT Ab42 transmembrane b-
sheet also results from residues E22 and D23 being located in the
hydrophobic membrane core, where they can interact with the
Figure 1. Initial structures for the MD runs. (A) b-sheet monomer, (B) b-sheet tetramer. The peptide is shown in cartoon and colored based on
the physicochemical properties of the residues: blue, basic; red, acidic; white, hydrophobic; green, polar. The bilayer phosphorus atoms are shown as
van der Waals spheres in tan color. Lipid tails and water molecules are not shown for clarity.
doi:10.1371/journal.pone.0078399.g001
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lower headgroups thereby destabilizing the b-sheet structure in
this region.
E22G. The most stable transmembrane b-sheet is observed
for the Arctic mutant as judged by the final MD structure (Fig. 2)
and the DSSP plot (Fig. S2 in File S1). The b-sheet stability of
E22G with 1561 residues in b conformation originates from the
removal of the negatively charged E22 residue, leading to overall
charge neutrality inside the membrane. The mutation increases
the hydropathy index from 8.6 for WT Ab42 to 11.7 for E22G
using the hydropathy scale of Kyte and Doolittle [78] (Table 1).
The stability of E22G Ab42 is further supported by the RMSF
result. The larger RMSD value and motion along z compared to
WT and most other Ab42 variants result from the tilt of E22G
Ab42 inside the POPC bilayer. The reorientation occurs after
200 ns of the MD simulation and is only observed for this mutant.
It is mainly driven by electrostatic interactions between E22G
Ab42 and both headgroup regions (Fig. S7 in File S1). Such a tilt is
in agreement with the experimental observation that the human
islet amyloid polypeptide adopts an orientation of about 48u
relative to the membrane surface when interacting with a
dipalmitoylphosphoglycerol (DPPG) monolayer, which might have
a strong damage to the lipid membrane [66].
D23G. In the Arctic-type mutant [69] the salt bridge between
residues D23 and K28 cannot be formed, which removes the
distance constraint between these two residues and thus destabi-
lizes the original bend region between G25 and K28 as shown in
Fig. 2 and Fig. S2 in File S1. Instead, residues D23–A30 adopt
mainly coil conformations, resulting in a widened loop region,
which allows E22 to interact with the upper headgroups. This
interaction is accompanied by an upward movement and bending
of the peptide (Fig. 3C), while the lipids surrounding the peptide in
the upper leaflet move downwards. This can be seen from the
positions of the lipid headgroups in Fig. 2 and will be discussed in
detail in the next section. The D23G mutant shows the largest
deviation from the starting structure, with an average RMSD
value of 0.65 nm. D23G is nonetheless stable as b-sheet, as
confirmed by the secondary structure analysis yielding, on
average, 15 residues in b conformation inside the membrane.
The interactions between K28 with the headgroups in the lower
leaflet prevent the b-sheet from completely moving to the upper
membrane–water interface. The balance between the interactions
of E22–upper headgroups and K28–lower headgroups gives rise to
a stable conformation, as demonstrated by the small fluctuations
according to the RMSF analysis. However, on longer time scales
the D23G mutant may migrate to the upper membrane-water
surface, adopting a membrane-adsorbed rather than a transmem-
brane conformation.
E22G/D23G. A stable transmembrane b-sheet is regained for
the double mutant E22G/D23G due to the removal of both
negative charges from residues 22 and 23, increasing the
hydropathy index to 14.8. The elimination of the salt bridge
between residues 23 and 28 leads to an extended loop region
between residues 22 and 30 in E22G/D23G Ab42, which induces
fluctuations in both transmembrane turns and reduces the b count
to 1461 residues. The deletion of charged groups removes any
electrostatic interactions involving residues 22 and 23 with the
lower headgroup region, while the interactions between the
positive charge of K28 and the lower headgroup anchors the
transmembrane position of the double mutant E22G/D23G,
which stabilizes this configuration.
K16M/K28M. From all considered mutations the K16M/
K28M double mutation has the highest transmembrane b content
with on average 1761 residues in b conformation. The mutation
K16M allows the peptide to move more easily along the
Figure 2. Ab42 monomers in a POPC bilayer. (Left) Final structures
at t= 500 ns. The coloring explanation for the peptides and lipids is
given in Fig. 1. (Right) Time averaged water density within the bilayer.
doi:10.1371/journal.pone.0078399.g002
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membrane normal [70,71], enabling the peptide to move
downwards (Fig. 3C) so that the turn residues G25–N27 are
exposed to the water phase and the charged residues E22 and D23
can better interact with the membrane–water interface (see final
structure in Fig. 2). These interactions reduce the conformational
dynamics of K16M/K28M as demonstrated by the RMSF
Figure 3. Structural analysis of Ab42 monomers in a POPC bilayer. (A) Backbone root mean square deviation, (B) backbone root mean square
fluctuation, (C) center of mass motion of residues 25 to 30, (D) number of transmembrane residues in b conformation for the b-sheet monomer of
wild type and mutant Ab42 : black, WT; magenta, E22G; ochre, D23G; red, E22G/D23G; blue, K16M/K28M; green, K16M/E22G/D23G/K28M.
doi:10.1371/journal.pone.0078399.g003
Table 1. Peptide and POPC bilayer properties resulting from membrane-inserted WT and mutant Ab42.
Ab42 hyropathy b count Area per lipid [A˚
2] bilayer # H2O
mutant index per peptide top bottom thickness [nm] passage
peptide-free{ n/a n/a 69.360 69.360.0 3.5160.0 0
monomer WT 8.6 1462 62.661.5 63.462.0 3.5560.04 1
E22G 11.7 1561 66.161.3 66.361.2 3.5460.05 3
D23G 11.7 1561 64.161.0 69.961.1 3.5160.04 5
E22G/D23G 14.8 1461 66.761.0 66.860.9 3.5460.05 2
K16M/K28M 20.2 17+1 67.360.9 66.761.0 3.5160.04 4
K16M/E22G/D23G/K28M 26.4 1462 64.861.1 67.260.8 3.5560.05 5
tetramer WT 8.6 1561 65.361.2 62.061.0 3.4960.05 5
E22G 11.7 1561 65.461.2 65.261.6 3.4660.04 8
D23G 11.7 1461 63.262.0 69.161.4 3.4860.05 22
Provided are the hydropathy index of WT and mutant Ab42 using the hydropathy scale of Kyte and Doolittle [78], time-averaged values for the number of
transmembrane residues in b conformation per peptide, the area per lipid headgroup in the top and bottom leaflet, the P–P bilayer thickness (each quantity with
standard deviation), and the number of water molecules passing through the POPC bilayer.
{The bilayer values for the peptide-free bilayer are taken from a 100 ns MD simulation of a POPC-only bilayer [49].
doi:10.1371/journal.pone.0078399.t001
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analysis, enabling it to form a stable transmembrane structure.
Furthermore, the substitution of both lysine residues with
methionine raises the hydropathy index of this Ab42 mutant to
20.2, causing it to be stable in a hydrophobic environment.
K16M/E22G/D23G/K28M. The quadruple mutant is also
stable as transmembrane b-sheet. However, compared to the other
Ab42 variants it is more flexible inside the membrane. The
complete removal of charged residues inside the membrane
induces peptide flexibility in the upper leaflet, involving residues
15–19 and 37–38 (see RMSF analysis in Fig. 3B). Because of the
missing constraint from the salt bridge between residues D23 and
K28 an extended loop is formed involving residues G22–A30. The
stability of this mutant as transmembrane b-sheet can thus be
attributed to i) the inherent stability of this sheet structure, and ii)
hydrophobic interactions between the peptide (its hydropathy
index is 26.4) and the membrane core. Furthermore, the structure
of the peptide is not perturbed by charged peptide residues
positioned in the membrane core.
Ab42 Monomer: Effects of Charge Removal on Lipid
Bilayer
Area per lipid. Table 1 summarizes the effects of the Ab42
mutants on lipid bilayer properties. It shows that the insertion of
Ab42 into a POPC bilayer leads to a decrease in the area per lipid
compared to the peptide-free bilayer. This area reduction is largest
for WT Ab42 with area values of 6–7 A˚
2 below the value for the
pure POPC bilayer. It results from electrostatic attraction and H-
bonds between Ab42 residues and lipid headgroups. Removal of
charged Ab42 residues results in smaller reductions of the area per
lipid with most values being only 2–4 A˚2 below the area of the
peptide-free POPC bilayer. Interestingly, for E22G, where peptide
charges were removed in the lower leaflet, not only the area per
lipid in the lower but also in the upper leaflet are larger compared
to WT Ab42. This result shows that the lipid packing in both
leaflets is coupled to each other. For D23G, on the other hand, the
area per lipid is reduced by about 5 A˚2 in the upper leaflet and
slightly increased in the lower leaflet compared to the peptide-free
POPC bilayer. This behavior can be explained by the conforma-
tional instability of the D23G mutant inside the bilayer, which
causes the whole peptide to move upward and bend to allow E22
to interact with the upper headgroups.
Bilayer thickness. This D23G–POPC interaction also leads
to a marked reduction of the bilayer thickness around the peptide,
which is for D23G most pronounced compared to the other
mutants (Figs. S8 and S9 in File S1). For the average bilayer
thicknesses we find that they are hardly affected by embedded
Ab42 with thickness changes within 60.05 nm compared to the
peptide-free POPC bilayer (Table 1). However, Fig. S9 in File S1
reveals that the POPC bilayer thickness around Ab42 is decreased
in order to improve the hydrophobic matching between bilayer
and Ab42, whose hydrophobic width is smaller than those of the
lipids (i.e., negative hydrophobic mismatch). The POPC bilayers
have a thickness of about 2.5–3.0 nm in the neighborhood of the
Ab42 peptides, which corresponds to the hydrophobic width of the
latter for b-sheet structures. However, for the quadruple mutant
we observe only minor changes to the bilayer thickness around the
peptide, because the four mutations increase the hydrophobic
width of the b-sheet. In general, the thinner bilayer region close to
Ab42 is compensated by a slight increase in thickness of the bilayer
as the distance from Ab42 increases [49,51,79]. Because of this
compensation effect the average bilayer thicknesses of the Ab42/
POPC systems are nearly identical to the thickness of the peptide-
free bilayer.
Lipid order. An increased bilayer thickness results from
increased lipid chain order. We therefore calculated the order
parameter SCD of the palmitoyl chains separately for lipids within
0.5 nm of Ab42, and for the lipids, which are more than 0.5 nm
away from Ab42. The results of this analysis are shown in Figs. S10
and S11 in File S1. In these figures we also present SCD of the
POPC-only bilayer obtained from a 100 ns MD run of the
peptide-free POPC bilayer [49] for comparison. The lipid order is
generally decreased around the peptide as evidenced by the SCD
values, which are smaller than the one for the peptide-free bilayer,
while the lipid order is marginally increased for the lipids further
away from the peptide. The lipid order reduction around Ab42 is
strongest for E22G, D23G and K16M/K28M, while removal of
all charged residues inside the membrane leads to such a good
integration of the quadruple Ab42 mutant into the hydrophobic
membrane core that the lipid order is almost unaffected by the
peptide. Especially carbon atoms 6–15 of the palmitoyl chains are
Figure 4. Ab42 tetramers in a POPC bilayer. (Left) Final structures
at t= 500 ns. The coloring explanation for the peptides and lipids is
given in Fig. 1. (Right) Time averaged water density within the bilayer.
doi:10.1371/journal.pone.0078399.g004
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not disturbed by the presence of this Ab42 variant. This finding is
in agreement with our observation that this particular mutant does
not decrease the bilayer thickness around the peptide.
Water permeation. The lipid disorder around Ab42 allows
water molecules to enter the membrane hydrophobic core in the
vicinity of the peptide. The water density profiles in Fig. 2 give an
estimate for the water penetration into the membrane. The density
profiles show that the headgroup regions of both bilayer leaflets
are fully solvated. In all systems we see water penetration into the
hydrophobic core, which is more prevalent in the top leaflet than
in the bottom leaflet. This cannot be explained by the area per
lipid as this quantity is generally smaller in the top than in the
bottom leaflet. Yet one would expect that a large area per lipid
allows water molecules to enter more easily. Instead, the
interaction of the N-terminal residues 1–16 with the membrane
surface, which disturbs headgroup packing (Fig. 2), facilitates the
entry of water molecules into the membrane.
Lipid disorder is another factor, which could increase water
penetration. The highest degree of water penetration is observed
for D23G, which also shows the largest lipid disorder in the upper
leaflet. Here, the water density has vanished only at z<–1.0 nm,
while for WT Ab42 and the other mutants the water densities are
zero between –1nmv
*
zv
*
+0.5nm. Water permeation is nonethe-
less small for D23G: only 5 water molecules passed through the
membrane within 500 ns (Table 1). In case of the quadruple
mutant we also observed 5 water translocation events, while for
the other Ab42 peptides this number was even smaller with values
between 1 (WT Ab42) and 4. For the peptide-free bilayer we did
not observe any permeation event within 100 ns. We thus
conclude that membrane-insertion of Ab42 monomer leads to a
slight increase of membrane permeability [49], which gets
amplified by lipid disorder resulting from peptide–lipid interac-
tions. However, the example of K16M/E22G/D23G/K28M
shows that other factors, such as the peptide charge distribution on
both sides of the membrane, also affect water permeation through
the membrane, since the lipid order is least impaired by this
peptide.
Ab42 Tetramer: Effect of Charge Removal on
Transmembrane Stability
Our motivation for studying transmembrane b-sheet tetramers
was to test whether they are more stable than the monomeric b-
sheets and may constitute likely membrane-bound Ab structures,
which are able to induce membrane damage. We performed the
simulations for the tetramer only for WT, E22G and D23G Ab42
as these are the biologically relevant Ab42 variants. The final
structures of these 500 ns MD simulation are shown in Fig. 4. The
results for the WT Ab42 tetramer in POPC were discussed in detail
in our previous study [49].
Oligomerization increases transmembrane stability. In
all three cases we observe that, unlike in the monomeric b-sheets,
the N-terminal b-hairpins are stable in the tetramer (see final
snapshots and DSSP plots in Figs. S1, S4 and S5 in File S1). The
b-hairpins interact with each other rather than with the bilayer
surface, causing the N-terminal regions to protrude above the
membrane instead of being adsorbed to the bilayer surface, as we
observed for the b-sheet monomers. In larger Ab assemblies
composed of mobile b-sheets [43,48] the water-exposed b-hairpins
structure might act as a funnel for cations to be inserted into the
membrane [49,80]. The transmembrane tetramers are more stable
than the b-sheet monomers, when the RMSD analysis in Figs. 3A
and 5A are compared. The average RMSD values for the
tetramers are between 0.20 and 0.30 nm, while they increased to
values of 0.35–0.65 nm for the monomers. The increased stability
of the tetramers can be explained by interpeptide interactions
[48,49]. The different stabilities of E22G and D23G in relation to
WT Ab42 tetramers will be now discussed in detail.
E22G. The Arctic mutant E22G is more stable than both WT
and D23G Ab42 tetramers as the RMSD analysis (Fig. 5A) and
secondary structure plot (Fig. S4 in File S1) reveal. The b-sheet
structure in the hydrophobic core is well conserved throughout the
simulation (Fig. 5D). The number of residues in b conformation
per peptide is very similar to the b content of the E22G monomer
and the WT Ab42 tetramer (Table 1). Interestingly, the b content
for the E22G tetramer is lowest between 100 and 200 ns when the
salt bridge D23–K28 in one of the four peptides is formed (Fig. S6
in File S1). That the salt bridge does promote b conformation in
this region was already observed during the last 100 ns of the WT
monomer simulation. In general, the lower turn region involving
residues 23–29 is the most flexible part in the peptides composing
the E22G tetramer. The RMSF plot (Fig. 5B) shows that these
residues fluctuate more than in both WT and D23G tetramer.
This can be explained with the deep insertion of the turn region
into the lower headgroup region, where the peptide structure
becomes disturbed by interactions with the headgroups and water
molecules. The downward motion between 100 and 200 ns is
revealed by the analysis of the peptides center of mass motion
along z (Fig. 5C). Because of interpeptide interactions the b-sheets
inside the membrane do not tilt as was observed for the E22G
monomer.
D23G. The D23G tetramer remains stable until around
350 ns. At that time, the RMSD (Fig. 5A) increases because the
peptides start bending towards the upper membrane surface.
However, this bending is not as strong as in the D23G monomer
as interactions between the peptides counteract the attractive
forces between residue E22 and the upper headgroups. Two of the
peptides of the D23G tetramer move upwards inside the bilayer,
causing the surrounding lipids to move with them. This movement
leads to a marked reduction of the bilayer thickness around the
tetramer. The lipid headgroups of the lower leaflet are pulled
upwards by interactions with with E22 and K28 in the turn region,
leading to membrane disruption (discussed below). As for the
D23G monomer, the absence of the salt bridge between residues
23 and 28 destabilizes the turn region thereby inducing
conformational flexibility. The b content for the D23G tetramer
belongs to the lowest values among the studied systems. While the
time-averaged number of residues in b conformation is 1560 for
the D23G monomer, it declined to 1461 for the tetramer. Thus,
opposite to WT and E22G the oligomerization does not help
stabilizing the b-sheet conformation in the D23G tetramer.
Furthermore, the amount of b fluctuation has increased for the
D23G tetramer. The structural flexibility is also evident in the
RMSF (Fig. 5B), which is for most residues larger for D23
compared to both WT and E22G. Surprisingly, only the turn
region involving residues V24–K28 fluctuates less than in the
E22G tetramer despite the extended loop region in D23G Ab42.
This is attributable to the interaction of D23 in E22G Ab42 with
the lower headgroups exposing the turn regions to the water
phase, which increases its flexibility.
Ab42 Tetramer: Effects on Lipid Bilayer
Area per lipid, bilayer thickness and lipid order. The
effects on the properties of the POPC bilayer resulting from
membrane-inserted WT, E22G and D23G Ab42 tetramers are
very similar to those observed for the corresponding monomers
(Table 1). The WT tetramer has on average the largest effect on
the area per lipid. E22G leads to area reductions of about 4 A˚2 per
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lipid in both leaflets, while D23G leaves the area per lipid in the
lower leaflet unaffected but reduces it by about 6 A˚2 in the upper
leaflet. The average bilayer thickness is 0.02–0.05 nm smaller
compared to the peptide-free bilayer. This reduction results from
the hydrophobic mismatch between Ab42 and the membrane core,
which compresses the bilayer near the peptides (Fig. S9 in File S1).
This in turn is accompanied by a reduction in lipid tail order,
which can be seen from the analysis of SCD of the lipids within
0.5 nm of the peptides (Fig. S12 in File S1). WT and D23G
tetramers have a larger disordering effect on nearby lipids than the
E22G tetramer. The latter observation differs from the finding
that E22G monomer disorders neighboring lipids. None of the
tetramers increased (or only marginally in the case of WT) the lipid
order in the palmitoyl chains .0.5 nm away from the peptides,
which explains why the average bilayer thickness is slightly
reduced, and not increased as for the Ab42 monomers.
Water permeation. The water density profiles for the Ab42
tetramers (Fig. 4) reveal an almost continuous water channel in
case of D23G. Only at z<0 the water density has almost declined
to zero. The increased membrane permeability for D23G tetramer
is also demonstrated by the translocation of 22 water molecules
during the simulation. This number is substantially larger than the
corresponding numbers for WT and E22G tetramer (5 and 8,
respectively) and for the monomers (#5 water translocations). The
increased water flow induced by the D23G tetramer is due to the
greater disruption of membrane integrity especially in the lower
leaflet. The water density profiles for WT and E22G tetramers also
reveal an increase in the average probability of finding water
inside the membrane compared to that of the monomers. Only for
–0.5 nmv
*
zv
*
+0.5 nm this probability is zero. Noteworthy, while
the WT tetramer enables more water molecules to reside inside the
membrane compared to the E22G tetramer, it supports fewer
water permeation events. This again shows that membrane
permeability in the vicinity of membrane-inserted amyloid peptide
is a complex process, which is governed by a multitude of factors,
such as lipid type, Ab42 conformation (as it influences the number
and strength of interactions between Ab42 and permeating water
molecules), and Ab42 oligomerization [49]. As in our previous
study [49], we observe that Ab42 oligomerization is an important
event, which causes an increase in membrane permeability. Here,
we have shown that the removal of peptide charges inside the
membrane further increases the amount of water inside the
membrane and the number of permeation events.
Conclusion
Based on the evidence that the cytotoxicity in AD originates
from interactions of Ab with neuronal cell membranes disturbing
the integrity of the membrane [15–17], we performed mutational
studies to investigate the transmembrane stability of various Ab42
mutants in a b-sheet conformation [48]. Our 500 ns MD
simulations of Ab1–42 mutants in a POPC bilayer reveal a similar
or increased stability compared to WT Ab42 for all mutants except
D23G. For the monomeric b-sheet we observed the highest
stability for the Arctic mutant E22G and the double mutant
Figure 5. Structural analysis of Ab42 tetramers in a POPC bilayer. (A) Backbone root mean square deviation, (B) backbone root mean square
fluctuation, (C) center of mass motion of residues 25 to 30, (D) number of transmembrane residues in b conformation for the b-sheet tetramer of wild
type and mutant Ab42 : black, WT; magenta, E22G; ochre, D23G.
doi:10.1371/journal.pone.0078399.g005
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K16M/K28M. The removal of positive charges by mutating K16
and K28 to methionine increases the hydropathy index of this
mutant Ab42 by a factor of 2.34, which gives rise to a stable
transmembrane b-sheet. The stability of the Arctic mutant E22G
can be attributed to the removal of the negative E22 charge in
combination with D23 and K28 interacting with the headgroups
of the lower leaflet, leading to charge neutrality of the peptide
inside the membrane. While the ‘Arctic-type’ D23G mutant has
the same hydropathy index as E22G Ab42, it is not stable as
transmembrane b-sheet, since the position of E22 inside the
membrane causes the peptide to bend towards the upper
membrane surface. The less toxic WT Ab42, on the other hand,
looses some of its b structure during the MD simulation due to its
overall negative charge inside the membrane. For APP it was
experimentally shown that the Arctic mutation alters the
transmembrane localization compared to WT APP, leading to
reduced levels of Arctic APP at the cell surface making it less
available for non-amyloidogenic cleavage. As a result, the extent
and subcellular location of Ab formation is changed, as revealed
by increased Ab levels, especially at intracellular locations [81].
Our simulation results reveal that also for Ab the Arctic mutation
increases its propensity to remain buried inside the lipid bilayer.
In our previous study [49] we demonstrated that a single
transmembrane Ab42 peptide is not sufficient to explain the
experimentally observed membrane damage resulting from
membrane-bound Ab, which causes cellular ionic imbalance
[18–20]. This finding allowed us to conclude that membrane
permeabilization by membrane-bound Ab as commonly observed
experimentally [15–17] must be due to transmembrane Ab
oligomers and not monomers as some studies conjectured
[82,83]. This conclusion is supported by the results of the current
study. Based on size and biochemical considerations it is also
evident that more than single Ab peptides enter the membranes
[20,36,84]. Therefore, the water translocation arising from a
monomeric transmembrane Ab b-sheet must not be overempha-
sized, yet its structural stability is a determinant for the stability of
the corresponding transmembrane oligomer. For instance, the
E22G Ab42 mutant is very stable both as monomeric and
tetrameric transmembrane b-sheet, while D23G is least stable in
either case. On the other hand, transmembrane D23G generates
the largest amount of membrane permeation compared to the
other monomers and tetramers.
This computational finding can be compared to experimental
observations. In situ AFM experiments with Arctic Ab40 exposed
to total brain lipid extract (TBLE) bilayers showed small
membrane-bound oligomeric aggregates with large areas of bilayer
disruption [36]. These areas were seen to be populated with stable
oligomers composed of 10–15 peptides per oligomer, rather than
with fibrillar aggregates as observed for WT Ab40. The same kind
of experiments with Iowa mutant (D23N) Ab40 revealed the
formation of stable oligomeric aggregates on the TBLE surface
within 2–3 hours [36]. However, after longer exposure (10–12
hours), the bilayer structural integrity was highly disrupted in small
areas arising from D23N Ab40 oligomers inside the bilayer [36].
Our molecular simulations revealed that E22G Ab has a higher
propensity to stay inside a membrane compared to D23G, while
D23G has a greater tendency to bind to the surface. However,
when D23G Ab is inside the membrane, it has a great capacity to
disrupt membrane integrity. Assuming the mutation location D23
to be the crucial factor, the experimentally observed behavioral
differences between membrane-bound E22G and D23N could be
explained based on our simulation results. Though, given the
physicochemical differences between Gly and Asn this conclusion
still needs to be proven by further simulations. To our knowledge,
no experiment on D23G Ab in the presence of a lipid membrane
has been carried out yet. NMR studies have revealed a large
destabilizing effect of the D23G mutation on the turn region
involving residues 21–30 [69], which is in agreement to our
computational results of transmembrane D23G Ab42.
Experimental studies of Ab mutant peptides revealed that the
aggregation propensity to form (proto)fibrils is not sufficient to
explain the observed in vivo toxicity of the Ab42 peptides [85,86].
Our results on the interactions between Ab42 and a POPC bilayer,
and the effect of Ab42 mutations on bilayer properties provide
further insight into the likely toxicity mechanism caused by
membrane-inserted Ab42 oligomers. We conclude that the higher
transmembrane stability of E22G and its increased membrane
disturbing effect compared to WT Ab are possible reasons for the
increased cytotoxicity of Arctic Ab. While our current simulations
are still rather short investigating only small oligomers–-simula-
tions of larger than tetrameric oligomers on the millisecond time
scale would be needed, which are yet prohibitively long with
respect to computing time–-we are able to state that Ab42
mutations have an effect on transmembrane stability and
membrane integrity. This should be motivation enough for
experimentalists and simulation scientists to perform further
studies on these systems.
Methods
Starting Structures
The initial Ab42 structure is a b-sheet, which was obtained from
a study of the Ab42 monomer and small oligomers using a global
optimization approach and an implicit membrane model [48]. In
this structure, the more hydrophobic C-terminal region starting
from residue 17 is fully inserted into the hydrophobic membrane
core, forming an antiparallel b-sheet with two turn regions. The
first turn ranges from residue 23 to 29, and the second one
involves residues 37 and 38. In solution, the G37–G38 hinge
structure has been identified as characteristic of Ab42 distinguish-
ing it from its C-terminal truncated relative Ab40 [87]. The first
turn is prominent in many Ab structures identified from
experiment [88–91] and simulation [92–94]. While each of these
models predict a distinct turn structure, they share the key
structural features of a salt bridge between Asp23–Lys28 and the
intramolecular hydrophobic cluster between Leu17/Phe19 and
Ile32/Leu34. We decided to use our b-hairpin model as starting
structure as it also provides a structural model for the more
hydrophilic residues 1–16, which form a b-hairpin outside the
membrane [48]. The N- and C-terminals were capped to nullify
the effect of terminal residues in peptide-lipid interactions. The
coordinates of the monomeric and tetrameric starting structures
are available from the Cambridge Cluster Database [95].
Structures obtained in the current work are available from the
authors upon request.
Molecular Dynamics Simulations
All MD simulations were performed with the GROMACS 4.0
package [96]. The Ab42 peptide was described using the
GROMOS96 53A6 force field [74], and the POPC lipids were
modeled with modified Berger force field parameters for use with
the GROMOS96 53A6 force field [77]. Initial coordinates of 128
lipids for POPC bilayer equilibrated with water for 40 ns were
obtained from Kukol’s work on lipid models [77]. The Ab42
peptide was inserted into the pre-equilibrated lipid membrane
using the INFLATEGRO script [97]. Once Ab42 was inserted into
the lipid membrane, the structures were solvated with SPC water
molecules, Na+ counterions were added to balance the peptide
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charge, and 0.1 M NaCl salt added to bring the system to the a
physiological salt concentration. The simulations were carried out
in a 6.566.569.5 nm3 box. An initial equilibration under
isothermal-isochoric conditions was performed for 100 ps during
which the protein heavy atoms and phosphorous atoms of the lipid
headgroups were restrained with a force constant of 1000 kJ
mol21 nm22. Here, a weak coupling thermostat with stochastic
velocity reassignment [98] using a coupling constant of 0.1 ps was
used to regulate the temperature of the peptide, lipids, and
solvent/ions separately at 298 K. The systems were then
equilibrated under isothermal-isobaric (NPT) conditions for
30 ns. For the NPT ensemble the Nose-Hoover thermostat
[99,100] was used to regulate the temperature along with
semiisotropic Parrinello-Rahman pressure coupling [101]. The
bilayer normal z-direction and xy-plane were coupled separately
with a time constant of 5.0 ps maintaining a constant pressure of 1
bar independently in all directions. An isothermal compressibility
of 4.56105 bar21 was applied in all box dimensions. Long-range
electrostatics were calculated using the Particle Mesh-Ewald
method [102,103] in connection with periodic boundary condi-
tions. Van der Waals and Coulombic interaction cutoffs were set
to 1.2 nm and the LINCS algorithm [104] was used to constrain
all bond lengths. Following equilibration, production MD runs
were performed for 500 ns for each system. Here the parameter
settings were similar to the NPT equilibration step, except that all
restraints were removed and the time constant for pressure
coupling was set to 2.0 ps. The time step for integration was 2 fs
with coordinates and velocities saved every 20 ps for analysis.
Analysis
The structural stability (RMSD) and dynamic properties
(RMSF) of Ab42 are analyzed for backbone atoms using
GROMACS tools. To characterize the effects of the peptide on
the orientational mobility of the lipid molecules we calculated the
lipid tail order parameter SCD defined as
SCD~ S
3 cos2 h{1
2
T, ð1Þ
where h is the angle between the C–H bond vector (in the
simulation) or the C–D bond vector (in the experiment) and the
bilayer normal. The angular brackets indicate averaging over
lipids and over time. The center of mass motion (COM) is
calculated for the turn region from residue 25 to 30 of Ab42 inside
the membrane hydrophobic core. The secondary structure of Ab42
was analyzed using the DSSP method [105] and the time-
averaged values for the number of transmembrane residues (i.e.,
between L17 and A42) in b conformation per peptide computed.
The salt bridge between D23 and K28 is considered to be formed
when the distance between the anionic carboxylate of D23 and the
cationic ammonium from K28 is ,4.5 A˚. We used the grid-based
membrane analysis tool GRIDMAT-MD to quantify the extent to
which the peptide affects the lipid headgroup arrangement and
bilayer thickness [106]. For the bilayer thickness we report
phosphate-to-phosphate (P–P) distances. To measure the depth of
water molecule penetration into the hydrophobic core, water
density profiles projected onto the z-direction were calculated,
while water permeation across the membrane was quantified using
VMD [107]. Time-averaged values were calculated for the last
400 ns of the 500 ns MD simulations.
Supporting Information
File S1 Contains: Figure S1 Secondary structure analysis for
the 500 ns MD simulations of WT Ab42 as (a) b-sheet monomer
and (b) b-sheet tetramer in a POPC bilayer. Figure S2 Secondary
structure analysis for the 500 ns MD simulations of mutant Ab42
monomer as (a) E22G, (b) D23G in a POPC bilayer. Figure S3
Secondary structure analysis for the 500 ns MD simulations of
mutant Ab42 monomer as (a) E22G/D23G, (b) K16M/K28M, (c)
K16M/E22G/D23G/K28M in a POPC bilayer. Figure S4
Secondary structure analysis for the 500 ns MD simulation of
E22G Ab42 tetramer in a POPC bilayer. Figure S5 Secondary
structure analysis for the 500 ns MD simulation of D23G Ab42
tetramer in a POPC bilayer. Figure S6 Minimum distance
between the anionic carboxylate of D23 and the cationic
ammonium from K28 in the WT monomer and the E22G
tetramer. Figure S7 Peptide-lipid interactions for the E22G
monomer decomposed into Coulomb and Lennard-Jones interac-
tions. Figure S8 Bilayer phosphate-to-phosphate thickness,
averaged over the last 400 ns of the 500 ns MD simulations of
WT Ab42 as (a) b-sheet monomer and (b) b-sheet tetramer in a
POPC bilayer. Figure S9 Bilayer phosphate-to-phosphate
thickness, averaged over last 400 ns of the 500 ns MD simulations
of Ab mutants (monomers and tetramers). Figure S10 Time-
averaged order parameter SCD of the palmitoyl chain of the POPC
lipids. Results are shown for WT, E22G and D23G Ab42
monomer. Figure S11 Time-averaged order parameter SCD of
the palmitoyl chain of the POPC lipids. Results are shown for WT,
E22G/D23G, K16M/K28M and K16M/E22G/D23G/K28M
Ab42 monomer. Figure S12 Time-averaged order parameter SCD
of the palmitoyl chain of the POPC lipids. Results are shown for
WT, E22G and D23G Ab42 tetramer.
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